About
Myosin Therapeutics develops first-in-class therapies targeting molecular motor proteins, such as non-muscle myosin II, to treat oncology and central nervous system diseases including glioblastoma.
Explore Myosin Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.